XML 41 R27.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Organization and Summary of Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Accounting Policies [Abstract] |
Contract Assets and Liabilities | The following table reflects the Company’s contract assets and contract liabilities:
| December 31, 2018 |  | December 31, 2017
| (In thousands)
Short-term unbilled receivables - included in accounts receivable and unbilled receivables | $ | 9,191 |  |  | $ | 4,590 |
Long-term unbilled receivables - included in other long-term assets | 16,481 |  |  | 9,475 |
Total contract assets | $ | 25,672 |  |  | $ | 14,065 |
Short-term deferred revenues, net | $ | 81,835 |  |  | $ | 78,774 |
Long-term deferred revenues | 10,582 |  |  | 10,623 |
Total contract liabilities | $ | 92,417 |  |  | $ | 89,397 |
Property and Equipment | Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:
Computer equipment and related software | 3 - 5 years
Leasehold and building improvements | Shorter of the lease term or the estimated useful life
Furniture and fixtures | 5 - 7 years
Equipment | 3 - 12 years
Schedule of New Accounting Pronouncements and Changes in Accounting Principles | Adoption of the standard related to revenue recognition impacted the Company’s reported results as follows:
| Year Ended December 31, 2017
| As Reported |  | Adjustment |  | As Adjusted
| (In thousands, except per share data)
Revenues |  |  |  |  |
Automation and Analytics | $ | 590,392 |  |  | $ | (3,451 | ) |  | $ | 586,941 |
Medication Adherence | 125,773 |  |  | — |  |  | 125,773 |
Gross profit |  |  |  |  |
Automation and Analytics | 281,949 |  |  | (3,451 | ) |  | 278,498 |
Medication Adherence | 40,139 |  |  | — |  |  | 40,139 |
Selling, general, and administrative expenses | 250,312 |  |  | (8,842 | ) |  | 241,470 |
Provision for (benefit from) income taxes | (21,484 | ) |  | (4,522 | ) |  | (26,006 | )
Net income | $ | 20,605 |  |  | $ | 9,913 |  |  | $ | 30,518 |
Net income per share - basic | $ | 0.55 |  |  | $ | 0.26 |  |  | $ | 0.81 |
Net income per share - diluted | $ | 0.53 |  |  | $ | 0.26 |  |  | $ | 0.79 |
| Year Ended December 31, 2016
| As Reported |  | Adjustment |  | As Adjusted
| (In thousands, except per share data)
Revenues |  |  |  |  |
Automation and Analytics | $ | 593,626 |  |  | $ | 3,285 |  |  | $ | 596,911 |
Medication Adherence | 98,997 |  |  | — |  |  | 98,997 |
Gross profit |  |  |  |  |
Automation and Analytics | 282,659 |  |  | 3,285 |  |  | 285,944 |
Medication Adherence | 31,141 |  |  | — |  |  | 31,141 |
Selling, general, and administrative expenses | 249,520 |  |  | (11,639 | ) |  | 237,881 |
Provision for (benefit from) income taxes | (2,551 | ) |  | 5,771 |  |  | 3,220 |
Net income | $ | 603 |  |  | $ | 9,153 |  |  | $ | 9,756 |
Net income per share - basic | $ | 0.02 |  |  | $ | 0.25 |  |  | $ | 0.27 |
Net income per share - diluted | $ | 0.02 |  |  | $ | 0.24 |  |  | $ | 0.26 |
| December 31, 2017
| As Reported |  | Adjustment |  | As Adjusted
| (In thousands)
Accounts receivable and unbilled receivables, net | $ | 189,227 |  |  | $ | 819 |  |  | $ | 190,046 |
Prepaid expenses | 36,060 |  |  | (15,668 | ) |  | 20,392 |
Prepaid commissions | — |  |  | 41,432 |  |  | 41,432 |
Other long-term assets | 39,841 |  |  | 9,475 |  |  | 49,316 |
Deferred revenues, net | 86,104 |  |  | (7,330 | ) |  | 78,774 |
Long-term, deferred revenues | 17,244 |  |  | (6,621 | ) |  | 10,623 |
Long-term, deferred tax liabilities | 28,579 |  |  | 12,867 |  |  | 41,446 |
Stockholders’ equity | 517,199 |  |  | 37,142 |  |  | 554,341 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contract balances and changes in contract balances. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(13)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e765-108305 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.10-01.(b)(6)) -URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e725-108305 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794 + Details
Name: | us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration